| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. | Director | Common Stock | 72.5K | $915K | $12.62 | May 24, 2024 | Direct |
| Context Therapeutics Inc. | Director | Stock Option (right to buy) | 19.3K | Sep 4, 2024 | Direct | ||
| Harpoon Therapeutics, Inc. | Chief Medical Officer | Common Stock | 0 | Mar 11, 2024 | Direct | ||
| Harpoon Therapeutics, Inc. | Chief Medical Officer | Employee Stock Option (Right to Buy) | 0 | Mar 11, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CNTX | Context Therapeutics Inc. | Sep 4, 2024 | 1 | $0 | 4 | Sep 5, 2024 | Director |
| CNTX | Context Therapeutics Inc. | Sep 4, 2024 | 0 | $0 | 3 | Sep 5, 2024 | Director |
| ZNTL | Zentalis Pharmaceuticals, Inc. | May 24, 2024 | 1 | $0 | 4 | May 29, 2024 | Director |
| ZNTL | Zentalis Pharmaceuticals, Inc. | May 24, 2024 | 0 | $0 | 3 | May 29, 2024 | Director |
| HARP | Harpoon Therapeutics, Inc. | Mar 11, 2024 | 3 | $0 | 4 | Mar 11, 2024 | Chief Medical Officer |
| HARP | Harpoon Therapeutics, Inc. | Jan 7, 2024 | 1 | $0 | 4 | Jan 9, 2024 | Chief Medical Officer |
| HARP | Harpoon Therapeutics, Inc. | Nov 26, 2023 | 1 | $0 | 4 | Nov 28, 2023 | Chief Medical Officer |
| HARP | Harpoon Therapeutics, Inc. | Jan 24, 2023 | 1 | $0 | 4 | Jan 26, 2023 | Chief Medical Officer |
| HARP | Harpoon Therapeutics, Inc. | Oct 3, 2022 | 1 | $0 | 4 | Oct 4, 2022 | Chief Medical Officer |
| HARP | Harpoon Therapeutics, Inc. | Oct 3, 2022 | 0 | $0 | 3 | Oct 4, 2022 | Chief Medical Officer |